Novabrim Eye Drop is a combined ophthalmic solution containing Timolol (0.5% w/v) and Brimonidine (0.2% w/v). This medication is indicated for the reduction of intraocular pressure in open-angle glaucoma and ocular hypertension. Timolol, a non-selective beta-blocker, works by decreasing aqueous humor production, while Brimonidine, an alpha-2 agonist, enhances outflow facilities. The synergistic action of these drugs in Novabrim Eye Drop provides effective IOP reduction with a potential for reduced frequency of dosing compared to monotherapy. However, it is crucial to adhere to the prescribed dosage and frequency to manage side effects such as ocular burning, stinging, and dryness. Regular eye examinations are recommended to monitor intraocular pressure and ocular health.